PE20011044A1 - Derivados de aminometil-fenil-ciclohexano sustituidos, procedimiento para su preparacion y medicamentos que contienen estos compuestos - Google Patents

Derivados de aminometil-fenil-ciclohexano sustituidos, procedimiento para su preparacion y medicamentos que contienen estos compuestos

Info

Publication number
PE20011044A1
PE20011044A1 PE2001000010A PE2001000010A PE20011044A1 PE 20011044 A1 PE20011044 A1 PE 20011044A1 PE 2001000010 A PE2001000010 A PE 2001000010A PE 2001000010 A PE2001000010 A PE 2001000010A PE 20011044 A1 PE20011044 A1 PE 20011044A1
Authority
PE
Peru
Prior art keywords
alkyl
phenyl
compounds
aminometil
procedure
Prior art date
Application number
PE2001000010A
Other languages
English (en)
Inventor
Babette-Yvonne Kogel
Wolfgang Strasburger
Claudia Putz
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20011044A1 publication Critical patent/PE20011044A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DE AMINOMETIL-FENIL-CICLOHEXANONA DE FORMULA I o Ia DONDE R1 Y R1' SON H, ALQUILO C1-C10, ALQUENILO C2-C10, ALQUINILO C2-C10, HALO, NR6R6', NO2 ENTRE OTROS; R6 Y R6' SON H, ALQUILO C1-C10, ALQUENILO C2-C10, ALQUINILO C1-C10, CICLOALQUILO C3-C7, HETEROCICLO, ENTRE OTROS; R1 Y R1' JUNTOS FORMAN EL RADICAL -CH=CH-CH=CH-; X ES H, HALO, CF3, OS(O2)C6H4-pCH3, OR7 ENTRE OTROS; R7 ES H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R4 Y R5 SON H, ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R4 Y R5 JUNTOS FORMAN ALQUILO C3-C7, HETEROCICLO; R2, R3 SON R9, YR9 DONDE Y ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R9 ES H, HALO CN, ENTRE OTROS. SON COMPUESTOS PREFERIDOS RAC-CIS-E-[-4-BENCILIDEN-2-(3-METOXI-FENIL)-CICLOHEXILMETIL]-DIMETILAMINA, RAC-TRANS-E-[-4-BENCILIDEN-2-(3-METOXI-FENIL)-CICLOHEXILMETIL]-DIMETILAMINA, ENTREOTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS. LOS COMPUESTOS DE FORMULA I , Ia SON UTILES PARA EL TRATAMIENTO DEL DOLOR
PE2001000010A 2000-01-05 2001-01-04 Derivados de aminometil-fenil-ciclohexano sustituidos, procedimiento para su preparacion y medicamentos que contienen estos compuestos PE20011044A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10000312A DE10000312A1 (de) 2000-01-05 2000-01-05 Substituierte Aminomethyl-Phenyl-Cyclohexanderivate

Publications (1)

Publication Number Publication Date
PE20011044A1 true PE20011044A1 (es) 2001-11-24

Family

ID=7626853

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000010A PE20011044A1 (es) 2000-01-05 2001-01-04 Derivados de aminometil-fenil-ciclohexano sustituidos, procedimiento para su preparacion y medicamentos que contienen estos compuestos

Country Status (27)

Country Link
US (1) US6673794B2 (es)
EP (1) EP1246793B1 (es)
JP (1) JP2003519210A (es)
KR (1) KR20020063294A (es)
CN (1) CN100379719C (es)
AR (1) AR033506A1 (es)
AT (1) ATE282021T1 (es)
AU (1) AU780547B2 (es)
BR (1) BR0016942A (es)
CA (1) CA2396304A1 (es)
CO (1) CO5251382A1 (es)
CZ (1) CZ20022337A3 (es)
DE (2) DE10000312A1 (es)
ES (1) ES2231312T3 (es)
HK (1) HK1050889A1 (es)
HU (1) HU225102B1 (es)
IL (2) IL150557A0 (es)
MX (1) MXPA02006700A (es)
NO (1) NO20022985L (es)
NZ (1) NZ520467A (es)
PE (1) PE20011044A1 (es)
PL (1) PL364873A1 (es)
PT (1) PT1246793E (es)
RU (1) RU2002120905A (es)
SK (1) SK286836B6 (es)
WO (1) WO2001049654A2 (es)
ZA (1) ZA200206151B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10112198A1 (de) * 2001-03-14 2002-09-19 Gruenenthal Gmbh Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine
DE10224107A1 (de) * 2002-05-29 2003-12-11 Gruenenthal Gmbh Kombination ausgewählter Opioide mit anderen Wirkstoffen zur Therapie der Harninkontinenz
HUE033042T2 (en) 2002-11-22 2017-11-28 Gruenenthal Gmbh Combination of selected analgesics with COX II inhibitors
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE102005034973A1 (de) * 2005-07-22 2007-02-15 Grünenthal GmbH Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
KR100684436B1 (ko) * 2005-09-08 2007-02-16 주식회사 다원 항산화, 지질과산화 억제에 따른 항노화, 항염증 및 거담 활성을 갖는 단풍마 및 가시오가피 혼합추출물을 함유하는 조성물
DE102005061430A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte Imidazolin-Derivate
DE102005061428A1 (de) * 2005-12-22 2007-08-16 Grünenthal GmbH Substituierte Cyclohexylmethyl-Derivate
DE102005061427A1 (de) * 2005-12-22 2007-06-28 Grünenthal GmbH Substituierte Oxadiazol-Derivate
BRPI0811639A2 (pt) 2007-05-31 2014-09-30 Sepracor Inc Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
CN113197935B (zh) * 2021-04-13 2022-06-24 开平健之源保健食品有限公司 一种厚朴提取物的提取方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223541A (en) * 1991-09-13 1993-06-29 Mcneilab, Inc. Tramadol n-oxide material, enantiomers and compositions thereof, and their use
IL112569A (en) * 1994-02-10 1999-12-22 Wyeth John & Brother Ltd Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19547766A1 (de) * 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19857475A1 (de) * 1998-12-14 2000-06-15 Gruenenthal Gmbh Substituierte Cycloheptene, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
EP1246793A2 (de) 2002-10-09
HUP0204001A3 (en) 2005-04-28
IL150557A (en) 2007-03-08
NO20022985L (no) 2002-08-28
KR20020063294A (ko) 2002-08-01
CN100379719C (zh) 2008-04-09
CN1437576A (zh) 2003-08-20
AR033506A1 (es) 2003-12-26
AU780547B2 (en) 2005-03-24
IL150557A0 (en) 2003-02-12
HUP0204001A2 (hu) 2003-11-28
ATE282021T1 (de) 2004-11-15
BR0016942A (pt) 2003-06-10
NO20022985D0 (no) 2002-06-20
MXPA02006700A (es) 2002-09-30
US6673794B2 (en) 2004-01-06
CZ20022337A3 (cs) 2002-11-13
NZ520467A (en) 2004-02-27
DE10000312A1 (de) 2001-07-12
ZA200206151B (en) 2003-11-03
WO2001049654A2 (de) 2001-07-12
CA2396304A1 (en) 2001-07-12
RU2002120905A (ru) 2004-01-10
DE50008626D1 (en) 2004-12-16
JP2003519210A (ja) 2003-06-17
SK9812002A3 (en) 2003-02-04
HU225102B1 (en) 2006-06-28
AU2843801A (en) 2001-07-16
CO5251382A1 (es) 2003-02-28
SK286836B6 (sk) 2009-06-05
US20030069288A1 (en) 2003-04-10
HK1050889A1 (en) 2003-07-11
PT1246793E (pt) 2005-03-31
ES2231312T3 (es) 2005-05-16
PL364873A1 (en) 2004-12-27
WO2001049654A3 (de) 2002-05-16
EP1246793B1 (de) 2004-11-10

Similar Documents

Publication Publication Date Title
PE20011044A1 (es) Derivados de aminometil-fenil-ciclohexano sustituidos, procedimiento para su preparacion y medicamentos que contienen estos compuestos
AR038476A1 (es) Derivados de quinazolina
AR016667A1 (es) Uso de una combinacion de un antiestrogeno mas progestina para la preparacion de un medicamento util para proveer la anticoncepcion y un kit deanticonceptivos adaptados para la administracion oral diaria
SE0104334D0 (sv) Therapeutic agents
ATE68473T1 (de) 1-phenyl-3-naphthalenyloxy-propanamine.
PA8561401A1 (es) Formas de sal e-2-metoxi-n-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi) fenilamino]quinazolin-6-il}alil) acetamida y procedimiento de produccion
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
PE20030856A1 (es) Esteres hidroxamato del acido n-(4-fenilsustituido)-antranilico
AR059501A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
SE0201194D0 (sv) New compounds
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
PA8475401A1 (es) Compuestos de sulfonilbenceno como agentes antiinflamatorios/analgesicos
FR2410641A1 (fr) Formes racemiques et optiquement actives de (biphenylyl-4)-2 n-(diethylamino alkyl) propionamides et de leurs sels utiles comme agents spasmolytiques et procedes de preparation
AR009374A1 (es) Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos.
AR008858A1 (es) Preparados farmaceuticos que contienen derivados 1-hidroxi-2-(1h) piridona, procedimiento para su obtencion y empleo de los mismos para la preparacion deun medicamento para el tratamiento y profilaxis de micosis cutaneas.
DE3750464D1 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
NO913023D0 (no) Nye bicykliske aminosubstituerte forbindelsr.
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
ES2036545T3 (es) Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.
SE9900190D0 (sv) New compounds
KR890012961A (ko) N-(저급알킬)-2-(3'-우레이도벤질)피롤리딘
ATE316960T1 (de) Pyrazolidinol-verbindungen
KR910004190A (ko) 온단세트론의 신규 의학 용도
MX9203068A (es) Compuestos activirales oralmente activos.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed